fda warning letter bpc-157 2024 2025 Inside 470 Letters From 2025: What Labs Need to Know BPC-157 as an Investigational Peptide
Description
It appears as a white lyophilized powder that is soluble in water
Sprays appear as breath freshener
Sweeney CJ, 2019, 'Enzalutamide with standard first-line therapy in metastatic prostate cancer', New England Journal of Medicine , 381, pp
Florio, M., Borrell, V
Proper storage slows these processes and maintains potency throughout the usable life of the vial
